Showing results (511-520 of 757) with videos related to
Sort By:
Pageof 76
Plos One|August 2, 2017
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factorsMaarten Arends, Marieke Biegstraaten, Derralynn A Hughes, et al.Kidney Medicine|November 2, 2023
Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) StudyMarkus P Schneider, Matthias Schmid, Jennifer Nadal, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2017
Mediterranean diet as the diet of choice for patients with chronic kidney diseasePhilippe Chauveau, Michel Aparicio, Vincenzo Bellizzi, et al.Stroke|April 8, 2017
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular RiskBernard Zinman, Silvio E Inzucchi, John M Lachin, et al.Journal of the American Society of Nephrology : JASN|July 18, 2015
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-UpMalte Lenders, Sima Canaan-Kühl, Johannes Krämer, et al.Journal of the American Society of Nephrology : JASN|September 11, 2016
HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis PatientsChantal Kopecky, Sanam Ebtehaj, Bernd Genser, et al.European Journal of Heart Failure|September 10, 2022
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trialMichael Böhm, Javed Butler, Felix Mahfoud, et al.ESC Heart Failure|October 4, 2021
Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trialDavid Fitchett, Silvio E Inzucchi, Bernard Zinman, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 15, 2022
Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort StudyMarkus P Schneider, Matthias Schmid, Jennifer Nadal, et al.Journal of Internal Medicine|December 16, 2021
Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD studyJohannes P Schwaiger, Barbara Kollerits, Inga Steinbrenner, et al.Pageof 76